Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment and management of treatment plans for myeloma often require individualized development, typically including drug therapy, rehabilitation interventions, regular follow-up visits, and more.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to disease changes. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the treatment of related myeloma.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.